Beita Pharmatech
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- Undisclosed
Investors
- 2
About Beita Pharmatech
Established in 2008, and based in Wuxi, China, Beita Pharmatech is a healthcare company that focuses on the development of isotopically labeled precursor compounds. It has obtained 16 patents and published 8 academic papers as of 2022. It has partnerships with the China Institute of Nuclear Power Research and Design, China Academy of Atomic Energy Research, China Academy of Engineering Physics, RC TRITEC and Cambridge Isotope Laboratories, Inc., Ltd. Its products can be divided into radioisotope labeled products, and stable isotope labeled products. The radioisotope labeled products include BTR-1 C-14 BaCO3, BTR-2 Urea-14C, and BTR-Pre C-14 labeled precursors. The stable isotope labeled products include BTS-1 C-13 BaCO3, and BTS-2 Urea-13C. It enables labelled for pharmaceuticals, pesticides, small molecules or bioactive molecules.
Who invested in Beita Pharmatech
2 investors across 2 rounds
See all investors in Beita Pharmatech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beita Pharmatech
Who invested in Beita Pharmatech?
Beita Pharmatech has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beita Pharmatech raised?
Beita Pharmatech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Beita Pharmatech last raise money?
Beita Pharmatech's most recent round on record is a Series B, in Mar 2021.
What does Beita Pharmatech do?
Established in 2008, and based in Wuxi, China, Beita Pharmatech is a healthcare company that focuses on the development of isotopically labeled precursor compounds.
Where is Beita Pharmatech headquartered?
Beita Pharmatech is headquartered in Jiangyin, China.
Which VCs invest in companies like Beita Pharmatech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Beita Pharmatech's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Beita Pharmatech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.